These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25210999)

  • 1. Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's disease.
    Qiu L; Zhang W; Tan EK; Zeng L
    ACS Chem Neurosci; 2014 Oct; 5(10):884-94. PubMed ID: 25210999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular network of microRNA targets in Alzheimer's disease brains.
    Satoh J
    Exp Neurol; 2012 Jun; 235(2):436-46. PubMed ID: 21945006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of microRNAs associated with Alzheimer's disease using oxidative stress cell model and different strains of senescence accelerated mice.
    Zhang R; Zhang Q; Niu J; Lu K; Xie B; Cui D; Xu S
    J Neurol Sci; 2014 Mar; 338(1-2):57-64. PubMed ID: 24423585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
    Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
    Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
    Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
    Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
    Satoh J
    J Pharmacol Sci; 2010; 114(3):269-75. PubMed ID: 20953120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
    Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
    Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in Alzheimer's disease.
    Delay C; Mandemakers W; Hébert SS
    Neurobiol Dis; 2012 May; 46(2):285-90. PubMed ID: 22285895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
    Schonrock N; Matamales M; Ittner LM; Götz J
    Exp Neurol; 2012 Jun; 235(2):447-54. PubMed ID: 22119426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression analysis of adult-onset Drosophila Alzheimer's disease model.
    Kong Y; Wu J; Yuan L
    Curr Alzheimer Res; 2014; 11(9):882-91. PubMed ID: 25274109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy.
    Karnati HK; Panigrahi MK; Gutti RK; Greig NH; Tamargo IA
    J Alzheimers Dis; 2015; 48(3):563-80. PubMed ID: 26402105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression.
    Hon LS; Zhang Z
    Genome Biol; 2007; 8(8):R166. PubMed ID: 17697356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatic analysis of microRNA expression in Parkinson's disease.
    Hao B; Chen X; Dai D; Zou C; Wu X; Chen J
    Mol Med Rep; 2015 Feb; 11(2):1079-84. PubMed ID: 25371140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.
    Ubhi K; Rockenstein E; Kragh C; Inglis C; Spencer B; Michael S; Mante M; Adame A; Galasko D; Masliah E
    Eur J Neurosci; 2014 Mar; 39(6):1026-1041. PubMed ID: 24304186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs Identify Shared Pathways in Alzheimer's and Parkinson's Diseases.
    Sadlon A; Takousis P; Alexopoulos P; Evangelou E; Prokopenko I; Perneczky R
    Trends Mol Med; 2019 Aug; 25(8):662-672. PubMed ID: 31221572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective distribution and dynamic modulation of miRNAs in the synapse and its possible role in Alzheimer's Disease.
    Garza-Manero S; Pichardo-Casas I; Arias C; Vaca L; Zepeda A
    Brain Res; 2014 Oct; 1584():80-93. PubMed ID: 24355599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.